The Cureus Journal of Medical Science is proud to introduce the Exceptional Responders in Breast Cancer case report publishing competition. We are seeking challenging breast cancer cases where patients exhibited unexpected or exceptional responses (positive or negative) to a therapy or diagnostic approach.

We are particularly interested in the diagnostic and/ or treatment options you considered, your clinical/scientific rationale for selecting the diagnosis, treatment or patient recommendations, and the patient outcome.

For example, did you:

• Use tissue or blood based genomic testing to create a treatment protocol that was not standard of care?
• Use a new blood based cancer detection test to determine if more tests were indicated or if treatment was working?
• Select a new surgical option or used a new surgical technique that reduced side effects?
• Use an imaging technology that changed the patient’s clinical pathway?

Our goal is to share the results with global oncologists and breast cancer patients who might benefit, so that positive experiences can be quickly explored and negative experiences quickly avoided. To encourage dissemination and cross-disciplinary awareness, all published materials will be indexed with PubMed Central and will be open-access.

The winner of this competition will be determined by general acclaim of the medical community using Cureus Scholarly Impact Quotient™ (SIQ™) crowdsourcing technology.

Program administration has been enabled through the financial support of Targeted Medical Educations (TME). Article selection, editorial review, peer review, publication, and competition winner determination are strictly independent of the sponsor.